Recently, Yang and Li (2023) reported that tricin has been shown to inhibit VEGFR-2 signaling by reducing ROS production in endothelial cells and decreasing VEGF expression by suppressing hypoxia-inducible factor-1α (HIF-1α) accumulation in tumor cells and damage.. The gene discussed is HIF1A; the disease is neoplasm.